
Sign up to save your podcasts
Or


Neuralink will launch a U.S. clinical trial in October to translate thoughts into text for patients with speech impairments, while Musk’s xAI faces questions over Grok’s “sexy” design and exposure of workers to explicit content. Miles Vega breaks it down on The Elon Effect.
By Cerebruh MediaNeuralink will launch a U.S. clinical trial in October to translate thoughts into text for patients with speech impairments, while Musk’s xAI faces questions over Grok’s “sexy” design and exposure of workers to explicit content. Miles Vega breaks it down on The Elon Effect.